Status:
COMPLETED
Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
Lead Sponsor:
Penn State University
Collaborating Sponsors:
Procter and Gamble
Conditions:
Respiratory Tract Diseases
Eligibility:
All Genders
2-11 years
Phase:
NA
Brief Summary
This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal co...
Eligibility Criteria
Inclusion
- Cough and congestion attributed to upper respiratory tract infection
Exclusion
- Children with signs or symptoms of more serious or treatable disease
- Presence of itchy, watery eyes or frequent sneezing
- Tachypnea (respiratory rate \>95%ile) or labored breathing
- Symptoms for 8 or more days
- History of asthma in the past 2 years, chronic lung disease, or seizure disorder
- History of an allergic reaction to camphor, menthol, eucalyptus, petrolatum, cedarleaf oil, nutmeg oil, thymol, turpentine oil, Over-the-counter medication containing VVR components
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT00743990
Start Date
October 1 2008
End Date
March 1 2010
Last Update
November 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States, 17033-0850